Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Hypothesis of the study: Neoadjuvant chemotherapy with Bevacizumab impairs postoperative outcome after resection of colorectal liver metastases.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Zurich
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• Patients with neoadjuvant chemotherapy prior to liver resection

Exclusion Criteria:

• Patients without neoadjuvant chemotherapy